Zepp Health (ZEPP) Current Deferred Revenue (2016 - 2024)
Zepp Health has reported Current Deferred Revenue over the past 9 years, most recently at $4.9 million for Q4 2024.
- Quarterly results put Current Deferred Revenue at $4.9 million for Q4 2024, up 2054.36% from a year ago — trailing twelve months through Dec 2024 was $4.9 million (up 2054.36% YoY), and the annual figure for FY2024 was $4.9 million, up 2022.75%.
- Current Deferred Revenue for Q4 2024 was $4.9 million at Zepp Health, up from $229580.9 in the prior quarter.
- Over the last five years, Current Deferred Revenue for ZEPP hit a ceiling of $13.8 million in Q4 2021 and a floor of $229580.9 in Q4 2023.
- Median Current Deferred Revenue over the past 5 years was $7.8 million (2020), compared with a mean of $7.1 million.
- Biggest five-year swings in Current Deferred Revenue: crashed 97.33% in 2023 and later soared 2054.36% in 2024.
- Zepp Health's Current Deferred Revenue stood at $7.8 million in 2020, then skyrocketed by 76.12% to $13.8 million in 2021, then tumbled by 37.5% to $8.6 million in 2022, then crashed by 97.33% to $229580.9 in 2023, then soared by 2054.36% to $4.9 million in 2024.
- The last three reported values for Current Deferred Revenue were $4.9 million (Q4 2024), $229580.9 (Q4 2023), and $8.6 million (Q4 2022) per Business Quant data.